Burning Rock Biotech Limited (NASDAQ: BNR), whose mission is to Guard Life via Science, focuses on developing innovative, reliable and clinically valuable products in the field of precision oncology and early detection. Its business consists of 1) therapy selection testing for cancer patients, 2) biomarker and companion diagnostic cooperation of global antineoplastic companies, and 3) multi-cancer early detection based on liquid biopsy.